The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART-Reference-Cited by-同舟云学术

The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART

Published:2009-08 Issue:8 Volume:81 Page:1323-1335
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Castor Delivette,Vlahov David,Hoover Donald R.,Berkman Alan,Wu Ying Feng,Zeller Barbara,Brechtl John,Hammer Scott M.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.21500/fullpdf

Reference44 articles.

1. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection;Albrecht;N Engl J Med,2001

2. Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection;Anderson;AIDS Res Hum Retroviruses,2008

3. Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure;Badri;AIDS Patient Care STDS,2007

4. Time trends in primary resistance to HIV drugs in the United Kingdom: Multicentre observational study;Cane;Br Med J,2005

5. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults;CDC;MMWR Recomm Rep,1992

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of highly experienced people with HIV undergoing salvage therapy with raltegravir;Medicine;2023-10-06

2. Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load;Journal of Antimicrobial Chemotherapy;2016-12-20

3. The Successful Application of a National Peer Advisory Committee for Physicians Who Provide Salvage Regimens to Heavily Antiretroviral-Experienced Patients in Mexican Human Immunodeficiency Virus Clinics;Open Forum Infectious Diseases;2014-09-01

4. Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals;Clinical Infectious Diseases;2014-01-14

5. Monitoring the emergence of resistance mutations in patients infected with HIV-1 under salvage therapy with raltegravir in Rio de Janeiro, Brazil: A follow-up study;Journal of Medical Virology;2012-10-10